Viewing nowCombinationCandesartan and Rosuvastatin Tablets 5/8 mg
Rosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hankook Hyutex Pharmaceutical Co., Ltd.

MFDS item code 202008721 · Approved 2020.12.11 · Insurance code 649105090
Treatment of hypertension and heart failure; improvement of dyslipidemia; suppression of atherosclerosis and prevention of cardiovascular disease
This medication is used for patients who need to take both components, Candesartan Cilexetil and Rosuvastatin. Candesartan Cilexetil is primarily used in patients with essential hypertension or heart failure with reduced left ventricular function when additional treatment with ACE inhibitors is needed or not tolerated. Rosuvastatin is used in combination with diet for patients with hyperlipidemia, particularly familial hypercholesterolemia and mixed hyperlipidemia, and as an adjunctive treatment for patients with homozygous familial hypercholesterolemia. Furthermore, it helps improve hyperlipidemia to slow the progression of atherosclerosis and aids in the treatment of dysbetalipoproteinemia. Additionally, it contributes to reducing the risk of stroke, myocardial infarction, and associated vascular revascularization in patients at high risk for cardiovascular disease. Therefore, this medication is used for the treatment of hypertension and heart failure, cholesterol regulation, and risk reduction for cardiovascular disease.
This medicine is intended for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg, exercising particular caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of 2 weeks or longer, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to this medication, severely compromised liver function, pregnant or breastfeeding women, and those with muscle disorders should not take this medication. Elderly patients, those with compromised liver function, or patients with hyperkalemia should take this medication with special caution, and regular blood tests and physical status checks are recommended. Symptoms such as muscle aches, weakness, headaches, dyspepsia may appear during treatment, and if these symptoms are severe or persistent, a physician should be consulted immediately. This medication may interact with other drugs, so if you are taking other medications, it is essential to inform your doctor or pharmacist. Women who may become pregnant should use appropriate contraceptive methods, and breastfeeding women should avoid taking this medication. In cases of overdose, hypotension and dizziness may occur, and immediate medical attention is required. Be cautious when driving or operating machinery as dizziness due to lowered blood pressure may occur. Store out of reach of children and do not transfer medications to other containers.
Headache, nasopharyngitis, localized infection, chest discomfort, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, nausea, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, tooth extraction, dizziness, positional dizziness, molluscum contagiosum, periodontitis, inflammation, foreign body sensation, musculoskeletal pain, neck pain, cataract, elevated blood sugar, decreased serum sodium, hypoglycemia, nephrolithiasis, cough, tooth extraction, paralysis, hypertension, syncope, facial flushing, weight gain, facial edema, dry mouth, sleep disturbances, decreased libido, forgetfulness, anorexia, increased appetite, tinnitus, dysgeusia, erectile dysfunction, angioedema, constipation, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory disorder, confusion, severe muscle weakness, oculobulbar weakness, hypotension, hyperkalemia, renal impairment, increased creatinine, increased urea, increased potassium, decreased sodium, elevated ALT, increased CK, dizziness, asthenia, fever, sensory disturbances, dyspepsia, gastroenteritis, tachycardia, palpitations, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, somnolence, dyspnea, rash, increased sweating, hematuria, intestinal vascular edema, diarrhea, elevated liver enzyme levels, hepatitis, jaundice, rash, urticaria, angioedema, rhabdomyolysis, arthralgia, myalgia, lumbago, renal impairment, acute kidney failure, interstitial pneumonia, shock, syncope, loss of consciousness, paralysis, hypertension, syncope, facial flushing, weight gain, facial edema, dry mouth, sleep disturbances, decreased libido, forgetfulness, anorexia, increased appetite, tinnitus, dysgeusia, erectile dysfunction, angioedema, constipation, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory disorder, confusion, severe muscle weakness, oculobulbar weakness, hypotension, hyperkalemia, renal impairment, increased creatinine, increased urea, increased potassium, decreased sodium, elevated ALT, increased CK, dizziness, asthenia, fever, sensory disturbances, dyspepsia, gastroenteritis, tachycardia, palpitations, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, somnolence, dyspnea, rash, increased sweating, hematuria, intestinal vascular edema, diarrhea, elevated liver enzyme levels, hepatitis, jaundice, rash, urticaria, angioedema, rhabdomyolysis, arthralgia, myalgia, lumbago, renal impairment, acute kidney failure, interstitial pneumonia, shock, syncope, loss of consciousness, lethargy, myalgia, muscle weakness, muscle cramps, increased CK, myopathy, rhabdomyolysis, acute kidney failure, musculoskeletal toxicity, myalgia, myopathy, rhabdomyolysis, increased CK levels, elevation of transaminases, liver function abnormalities, liver failure, hepatitis, jaundice, thrombocytopenia, increased serum creatinine, acute kidney failure, oliguria
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best stored at room temperature between 1 to 30 degrees Celsius.
Pink circular film-coated tablets
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hankook Hyutex Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.